Cargando…
Linear Cyclodextrin Polymer Prodrugs as Novel Therapeutics for Niemann-Pick Type C1 Disorder
Niemann-Pick Type C1 disorder (NPC) is a rare lysosomal storage disease characterized by the accumulation of cholesterol in lysosomes. NPC has no FDA approved treatments yet, however 2-hydroxypropyl-β-cyclodextrin (HPβCD) has shown efficacy for treating the disease in both mouse and feline NPC model...
Autores principales: | Kulkarni, Aditya, Caporali, Paola, Dolas, Atul, Johny, Soniya, Goyal, Sandeep, Dragotto, Jessica, Macone, Alberto, Jayaraman, Ramesh, Fiorenza, Maria Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015065/ https://www.ncbi.nlm.nih.gov/pubmed/29934581 http://dx.doi.org/10.1038/s41598-018-27926-9 |
Ejemplares similares
-
Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis
por: Caporali, Paola, et al.
Publicado: (2016) -
Efficacy and ototoxicity of different cyclodextrins in Niemann–Pick C disease
por: Davidson, Cristin D., et al.
Publicado: (2016) -
The appearance of phagocytic microglia in the postnatal brain of Niemann Pick type C mice is developmentally regulated and underscores shortfalls in fine odor discrimination
por: Rava, Alessandro, et al.
Publicado: (2022) -
Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease
por: Collins, Christopher J., et al.
Publicado: (2017) -
Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
por: Yergey, Alfred L., et al.
Publicado: (2017)